Mechanical thrombectomy safe and effective for childhood stroke

  • Sporns PB & al.
  • JAMA Neurol
  • 14 Oct 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Endovascular recanalization is safe and effective when used in real-world practice to treat paediatric patients up to age 18 years experiencing acute stroke due to large-vessel occlusion.

Why this matters

  • Lack of high-level evidence supporting this treatment for children.
  • Difficulty of randomising pediatric stroke patients.

Key results

  • Location of occlusion treated:
    • 86% anterior circulation.
    • 14% posterior circulation.
  • Overall, 22% of children received concomitant intravenous thrombolysis.
  • Neurologic outcomes:
    • Improvement in Pediatric National Institutes of Health Stroke Scale score from 14.0 (interquartile range [IQR], 9.2-20.0) at admission to 4.0 (IQR, 2.0-7.3) at day 7.
    • Stable median modified Rankin scale score of 1.0 (IQR, 0-1.6) at 6 months and 1.0 (IQR, 0-1.0) at 24 months.
  • Complications:
    • 1% postinterventional bleeding.
    • 5% transient peri-interventional vasospasm.
  • Lower rate of symptomatic intracerebral haemorrhages in study pediatric cohort vs in HERMES meta-analysis of trials among adults (1.37% vs 2.79%).

Expert comment

  • In an editorial, Christine Fox, MD, MAS; Nomazulu Dlamini, MBBS, MSc, PhD, write, “Centres considering mechanical embolectomy in children should be prepared for this procedure by establishing local guidelines and multidisciplinary teams in consultation with paediatric neurologists with stroke expertise. Thrombectomy should ideally be performed by neurointerventional radiologists who have experience with both pediatric endovascular procedures and stroke embolectomy.”

Study design

  • Retrospective cohort study spanning 2000-2018 and 27 US, European stroke centres, among all 73 paediatric patients (
  • Main outcome: neurologic improvement (decrease in Pediatric National Institutes of Health Stroke Scale score).
  • Funding: None disclosed.

Limitations

  • Potential selection bias.
  • Heterogeneity of protocols, patients across centers.
  • Lack of control group.
  • Uncertain generalisability.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit